Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients.

Raeisi, Farzaneh; Mahmoudi, Esmaeil; Dehghani-Samani, Mina; Hosseini, Seyedeh Sahar Ebrahimi; Ghahfarrokhi, Ameneh Mehri; Arshi, Asghar; Forghanparast, Kayvan; Ghazanfari, Samaneh

Raeisi, Farzaneh; Mahmoudi, Esmaeil; Dehghani-Samani, Mina; Hosseini, Seyedeh Sahar Ebrahimi; Ghahfarrokhi, Ameneh Mehri; Arshi, Asghar; Forghanparast, Kayvan; Ghazanfari, Samaneh.

Afiliação

Raeisi F; Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Mahmoudi E; Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Dehghani-Samani M; Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Hosseini SSE; Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.
Ghahfarrokhi AM; Biotechnology Research Center, Bushehr Branch, Persian Gulf University, Bushehr, Iran.
Arshi A; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Forghanparast K; Young Researchers and Elite Club, Najafabad Branch, Islamic Azad University, Najafabad, Iran.
Ghazanfari S; Canoga Park Urgent Care Family Medicine, 20905 Sherman Way, Canoga Park, CA 91303, USA.

Mol Ther Oncolytics ; 16: 230-237, 2020 Mar 27.

Article em En | MEDLINE | ID: mdl-32123723

Palavras-chave

CLL; biomarker; breast cancer; miRNAs; qRT-PCR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google